INCR
Intercure Ltd
NASDAQ · Pharmaceuticals
$0.88
+0.02 (+2.70%)
Open$0.86
Previous Close$0.86
Day High$0.90
Day Low$0.86
52W High$46.26
52W Low$20.49
Volume—
Avg Volume364.5K
Market Cap148.73M
P/E Ratio13.98
EPS$2.72
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+4,423.3% upside
Current
$0.88
$0.88
Target
$39.95
$39.95
$34.56
$39.95 avg
$63.39
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 54.91M | 56.95M | 44.24M |
| Net Income | 8.56M | 10.61M | 8.30M |
| Profit Margin | 15.6% | 18.6% | 18.8% |
| EBITDA | 18.71M | 17.54M | 14.43M |
| Free Cash Flow | 13.25M | 14.62M | 7.88M |
| Rev Growth | +12.7% | -4.9% | +12.1% |
| Debt/Equity | 0.21 | 0.25 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |